The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

STERIS delivered results for Q2 that were ahead of Wall Street’s expectations, with management attributing the performance to broad-based volume growth across its Healthcare, AST (Applied ...

“Fiscal 2026 was another record year for STERIS with 9% revenue growth, 7% on a constant currency organic basis,” said President, CEO & Director Daniel Carestio, adding that the company delivered “10% ...

Burton said, "we do have a bit of a slowdown in the second half," noting tough comparisons in AST and decelerating healthcare services growth. Management described increased tariffs as a headwind, ...

Daniel A Carestio's most active month to dispose stocks was the month of September. 2020 saw Daniel A Carestio paying a total of $2,630,085.00 for 104,208 shares, this is the most they've acquired in ...

In the news: Carestio became president and CEO of medical equipment company Steris in 2021, after previously serving as its COO. He had been with the company for more than 20 years in a variety of ...

In the news: The medical equipment and life sciences company in April said it had agreed to sell its dental segment to Peak Rock Capital, a middle-market private investment firm, for $787.5 million in ...

STERIS’s fourth quarter results received a negative reaction from the market despite surpassing Wall Street’s revenue expectations and reporting adjusted earnings per share in line with consensus.

Daniel A Carestio's most active month to dispose stocks was the month of September. 2020 saw Daniel A Carestio paying a total of $2,630,085.00 for 104,208 shares, this is the most they've acquired in ...